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Abstract  A  cross-sectional  study  was  carried  out  on  cats  attending  the  Small  Animal  Hospital
at the  Faculty  of  Veterinary  Sciences  of  the  University  of  Buenos  Aires  to  assess  the  prevalence
and associated  risk  factors  of  Feline  immunodeﬁciency  virus  (FIV)  and  Feline  leukemia  virus
(FeLV) in  the  city  of  Buenos  Aires,  Argentina.  Blood  samples  from  255  cats  with  symptoms
compatible  with  FIV  or  FeLV  infection,  collected  between  2009  and  2013  were  analyzed  by
serology (immunochromatography,  IA)  and  by  hemi-nested  PCR  (n-PCR).  The  IA  and  n-PCR  assays
showed similar  percentages  of  positivity  for  FIV  while  the  n-PCR  test  was  more  sensitive  for  FeLV.
Differences  between  the  diagnostic  tests  and  their  choice  according  to  the  age  of  the  animal
are discussed.  The  clinical  histories  of  ninety  of  the  255  cats  showed  blood  proﬁles  similar
to others  previously  reported  and  revealed  a  higher  risk  of  infection  in  male  adult  cats  with
outdoor access.
©  2016  Asociacio´n  Argentina  de  Microbiolog´ıa.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Criterios  diagnósticos  para  la  infección  por  el  virus  de  la  inmunodeﬁciencia  felina  y  el
virus  de  la  leucemia  felina  en  gatos  domésticos  de  Buenos  Aires,  Argentinafelina; Resumen  Para  determinar  la  prevalencia  en  la  ciudad  de  Buenos  Aires  del  virus  de  la  inmun-
el  virus  de  la  leucemia  felina  (FeLV),  y  analizar  los  factores  de  riesgo
os  a  ellos,  se  realizó  un  estudio  transversal  en  gatos  atendidos  en
nimales  de  la  Facultad  de  Ciencias  Veterinarias  de  la  Universidad
ron  por  serología  (inmunocromatografía  [IA])  y  por  hemi-nested  PCRVirus  de  la  leucemia
felina;
Inmunocromatografía;
PCR
odeﬁciencia  felina  (FIV)  y  d
que pudieran  estar  asociad
el Hospital  de  Pequen˜os  A
de Buenos  Aires.  Se  analiza
(n-PCR) 255  muestras  de  sangre  de  gatos  con  síntomas  compatibles  con  infección  por  FIV  o  FeLV.
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La  IA  y  la  n-PCR  revelaron  porcentajes  similares  de  animales  positivos  para  FIV,  mientras  que
para FeLV  el  diagnóstico  por  n-PCR  resultó  más  sensible.  Se  discuten  las  diferencias  halladas
entre los  métodos  diagnósticos  y  su  elección  según  la  edad  del  animal.  Las  historias  clínicas  de
90 de  los  255  gatos  mostraron  perﬁles  sanguíneos  similares  a  otros  ya  reportados  y  revelaron  el
mayor riesgo  de  infección  con  ambos  virus  en  machos  adultos  con  acceso  al  exterior.
© 2016  Asociacio´n  Argentina  de  Microbiolog´ıa.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este  es  un
art´ıculo Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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wFeline  immunodeﬁciency  virus  (FIV)  and  Feline  leukemia
irus  (FeLV)  are  retroviruses  that  can  infect  both  domestic
nd  wild  cats3,7.  FIV,  which  is  a  lentivirus,  produces  a  pro-
ressive  deterioration  of  the  immune  system  of  the  animal
eading  to  prominent  secondary  infections,  in  a  very  similar
ashion  to  the  Human  immunodeﬁciency  virus  type  1.  FeLV,
hich  is  a  gammaretrovirus, is  associated  with  proliferative,
egenerative  and  oncogenic  diseases  in  erythroid,  myeloid
nd  lymphoid  cell  lineages.  Diagnosis  of  these  infections  can
e  performed  by  different  methods.  Detection  of  antibod-
es  against  structural  proteins  is  the  choice  for  FIV  diagnosis
sing  immunochromatography-based  kits.  The  same  kits  are
esigned  to  detect  FeLV  antigens8.  Alternatively,  polymerase
hain  reaction  (PCR)  tests  targeting  conserved  sequences
uch  as  those  present  within  the  pol  region  can  also  be
sed2,6.
Reports  of  the  prevalence  of  these  agents  around  the
orld  are  numerous.  However,  in  Latin  America  information
s  scarce.  There  have  been  few  reports  on  the  FIV  situa-
ion  in  Argentina,  where  speciﬁc  antigens  and  antibodies
ave  been  detected  in  cats  since  199413.  In  order  to  investi-
ate  the  prevalence  of  these  infections  in  domestic  cats  in
he  city  of  Buenos  Aires  we  tested  a  total  of  255  cats  with
linical  symptoms  compatible  with  FIV  or  FeLV  infection  in
he  period  2009--2013.  These  animals  were  treated  in  the
mall  Animal  Hospital  at  the  Faculty  of  Veterinary  Sciences
University  of  Buenos  Aires)  and  they  resided  in  the  city  of
uenos  Aires  and  their  surrounding  areas.  Testing,  which  is
rdered  on  a  regular  basis  by  clinicians  in  suspected  cases,
as  performed  with  a  commercial  immunochromatographic
ssay  (IA)  and  by  a  nested  PCR  (n-PCR).  These  tests  were
erformed  at  the  Virology  Department  of  the  same  faculty.
nly  samples  from  adult  cats  (>2  years  old)  were  included
n  this  study.  Cats  under  two  years  old  were  not  tested  due
o  the  possible  interference  of  maternal  antibodies.  Clini-
al  and  laboratory  data  were  also  examined  and  compared
etween  infected  and  uninfected  cats  as  well  as  with  data
rom  other  countries.
Blood  samples  (2  ml)  were  collected  in  tubes  containing
%  EDTA  and  processed  during  the  following  12  h.  They  were
ivided  into  two  aliquots;  one  was  centrifuged  at  2000  rpm
or  15  min  and  the  collected  serum  was  tested  for  anti-
odies  against  FIV  (gp40)  and  antigens  for  FeLV  (p27  group
peciﬁc)  with  a  commercial  immunochromatographic  assay
Speed  DUO  FeLV-FIV,  BIO  VETO  Test®,  BVT  Virbac).  The
ther  aliquot  was  centrifuged  with  1  ml  of  Histopaque®-1077
Sigma-Aldrich),  at  400  ×  g  for  15  min.  The  opaque  interface
ontaining  the  mononuclear  cell  fraction  was  carefully  aspi-
ated.  Finally,  proviral  DNA  extraction  was  performed  with
igh  Pure  Viral  Nucleic  Acid  Kit® (Roche).
a
m
a
aA  n-PCR  was  performed  for  FeLV  following  a  previously
escribed  procedure  that  ampliﬁes  a  166  base-pair  (bp)
ragment  from  the  ul3  gene9.  For  FIV,  a  hemi-nested  PCR
rotocol  that  ampliﬁes  a  338  bp  fragment  from  p24  of  the
ag  gene  was  adapted  from  previous  studies5.
Both  PCR  were  carried  out  in  a  total  volume  of  50  l,
ontaining  0.2--1  g  of  genomic  DNA,  1.5  mM  MgCl2, 1 mM
ach  of  the  four  deoxynucleotide  triphosphates,  50  pmol
f  each  primer  for  FIV  (for  both  rounds)  and  3.5  pmol  and
5  pmol  for  FeLV  (ﬁrst  and  second  round,  respectively),
 U  of  GoTaq  polymerase  and  5  l of  10X  GoTaq  buffer
Promega).
Negative  and  positive  controls  (DNA  from  infected  cats)
ere  included  in  each  assay.  Cycling  conditions  for  both
ounds  of  the  FIV  hemi-nested  PCR  were:  one  cycle  at  94 ◦C
or  2  min,  35  cycles  at  94 ◦C  for  30  s,  52 ◦C  for  30  s and  elon-
ation  at  72 ◦C  for  30  s,  and  ﬁnally,  a  10-min  elongation  stage
t  72 ◦C.  For  FeLV  a  previously  described  n-PCR  method  pro-
osed  by  Hofmann-Lehmann  et  al.9 was  followed.  Primers
or  both  ampliﬁcations  are  detailed  in  Table  1. Complete
linical  histories  were  only  available  for  90  cats.  The  group
nalyzed  was  composed  by  female  and  male  cats  and  was
ivided  into  two  categories:  juvenile  cats  (two  to  ﬁve  years
ld)  and  elderly  cats  (more  than  ﬁve  years  old).  To  determine
he  association  between  positivity  and  the  clinical  variables
n  2 test  and  a  two-tailed  Fisher  corrected  test  were  per-
ormed  using  the  Epi  InfoTM 7  (7.1.5)  software.  The  odds  ratio
OR)  was  calculated  using  the  same  program.  The  level  of
igniﬁcance  was  p  >  or  =0.05.
Results  indicated  that  of  the  total  of  255  samples,  the
verall  prevalence  by  IA  was  21.45%  (55/255)  for  FIV  and
.69%  (14/255)  for  FeLV,  while  20.34%  (52/255)  for  FIV  and
1.82%  (30/255)  for  FeLV  were  observed  by  n-PCR  (Fig.  1A).
nly  3  samples  of  the  255  (0.9%)  were  positive  for  both
iruses  by  n-PCR.  Age  distribution  of  the  infected  animals
howed  that  cats  between  eight  and  eleven  years  old  had
he  highest  prevalence  (Fig.  1B).
The  clinical  histories  provided  information  about  the  clin-
cal  signs,  laboratory  diagnosis  and  anamnesis  data  at  the
oment  of  the  veterinary  consultation.  From  this  informa-
ion,  it  was  found  that  78.6%  of  FIV  or  FeLV  positive  cats
ere  male  while  only  21.4%  were  female.  Sixty  two  percent
ere  castrated  while  70%  had  access  to  the  outside  environ-
ent  or  lived  with  other  cats.  In  relation  to  the  clinical  signs,
2.9%  had  oral  lesions  (ulcers  or  gingivitis),  41%  experienced
eight  loss  and  38.1%  had  skin  infections.  Blood  cell  counts
nd  protein  values  data  showed  that  36%  of  the  positive  ani-
als  had  an  alteration  in  the  ratio  of  total  proteins  versus
lbumin  and  66%  showed  anemia  or  polymorphonuclear  cell
bnormalities  (Table  2).
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Table  1  Primers  used  for  FIV  and  FeLV  n-PCRs.  The  reverse  primer  for  FIV  ampliﬁcation  was  the  same  for  both  rounds
Forward  Reverse
External  round  FIV  5′ GGCATATCCTATTCAAAGAG  3′ 5′ AAGAGTTGCATTTTATATCC  3′
Internal  round  FIV  5′ CTGCTTGTTGTTCTTGAGTT  3′ 5′ AAGAGTTGCATTTTATATCC  3′
External  round  FeLV  5′ AAAATTTAGCCAGCTACTGCAG  3′ 5′ GAAGGTCGAACTCTGGTCAACT  3′
Internal  round  FeLV  5′ TTACTCAAGTATGTTCCCATG  3′ 5′ CTGGGGAGCCTGGAGACTGCT  3′
g
M
a
sFIV  and  FeLV  are  important  feline  pathogens  because
they  give  opportunity  to  other  infectious  agents  to  invade
and  multiply  in  the  same  host  they  infect.  FIV  and  FeLV
positive  cats  can  also  act  as  a  maintenance  niche  for  other
feline  pathogens  such  as  Feline  herpes  virus  type  1,  Feline
calicivirus,  or  zoonotic  agents  such  as  Mycoplasma
haemofelis,  Mycobacterium  tuberculosis, Toxoplasma
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Figure  1  (A)  Percentage  of  positive  and  negative  samples  for
both viruses  using  both  techniques.  (B)  Age  composition  his-
togram  of  positive  cats.
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nondii, mycotic  agents  such  as  Cryptococcus  neoformans,
alassezia  pachydermatis  and  Microsporum  canis. In
ddition,  infected  domestic  cats  can  endanger  wild  feline
urvival  because  they  are  a  permanent  source  of  infectious
iruses.
In  this  study  we  present  preliminary  data  on  the  preva-
ence  of  FIV  and  FeLV  in  the  city  of  Buenos  Aires,  Argentina,
or  a  group  of  255  cats  obtained  between  2009  and  2013
sing  two  different  kinds  of  tests.  Traditional  testing  for
hese  infections  is  based  on  antibody  detection  (FIV),
ntigen  detection  (FeLV)  o  direct  detection  of  genomic
equences  (PCR).  In  Argentina  there  are  no  FIV  commercial
accines  available,  therefore  any  positive  serology  would
ndicate  exposure  to  the  infectious  agent  or  the  presence  of
aternal  antibodies.
Due  to  the  different  tests  available,  discrepancies  can  be
ound  in  the  results  obtained  with  them  depending  on  what
s  detected  and  which  kit  is  used.  Furthermore,  although
everal  IA  tests  are  available,  the  FIV  antigens  utilized  in
he  solid  phase  of  the  kit  can  be  different.  In  addition,  the
articular  stage  of  the  disease  makes  a  test  more  suitable
han  the  other  (see  below).  These  factors,  as  well  as  the
peciﬁc  cultural  characteristics  of  each  country,  make  the
omparison  of  prevalence  values  very  challenging.  Interest-
ngly,  similar  IA  values  have  been  reported  from  different
ountries  utilizing  comparable  tests  (IDEXX  SNAP  FIV/FeLV
ombo  Test  Diagnostic  Kit  or  SNAP  Feline  Triple  Test)  includ-
ng:  Spain  15.6%  of  positive  cats  for  FeLV  and  8.3%  for  FIV1;
exico  5%  for  FeLV  and  2.5%  for  FIV12; Poland  6.4%  for  FeLV
nd  4.3%  for  FIV14;  Canada  6.2%  for  FeLV  and  2.2%  for  FIV
Island  of  Newfoundland)11. However,  our  combined  data
rom  IA  and  n-PCR  tests  from  domestic  cats  in  Argentina
ndicates  higher  FIV  rates  than  the  ones  reported  in  other
arts  of  the  world,  although  the  values  are  similar  to  oth-
rs  informed  in  cities  of  neighboring  countries.  For  example,
7.5%  of  FIV  positive  cats  diagnosed  by  PCR4 was  reported
n  Rio  Grande  do  Sul,  Brazil.  In  the  same  city  but  using  an
ndirect  immunoﬂuorescence  antibody  assay  for  FeLV  p27
ntigen  around  11%  of  the  animals  tested  were  found  posi-
ive  for  FeLV.  By  measuring  a  different  parameter  (PCR  of
enomic  sequences)  we  obtained  similar  values  for  FeLV,
lthough  the  numbers  are  higher  than  those  observed  by  IA
ssays  (Table  1).
The  FIV  positive  percentages  found  in  our  work  were
imilar  using  both  tests  (IA  and  n-PCR)  in  spite  of  detec-
ing  different  parameters.  In  contrast,  FeLV  results  showed
igher  sensitivity  with  the  PCR  assay,  as  expected.  It is  evi-
ent  that  an  important  factor  in  the  outcome  of  the  test  is
he  moment  when  the  sample  is  collected.  Therefore,  a  good
namnesis  with  the  owner  and  a  detailed  clinical  analysis  are
ecessary  to  choose  the  most  suitable  diagnostic  method
296  S.  Galdo  Novo  et  al.
Table  2  Risk  variables  using  the  Fisher’s  exact  test  for  positive  (FIV  or  FeLV)  cats
Study  in  positive  (FIV  or  FeLV  or  both)  n  =  42  and  negative  cats  n  =  48
Positive  (%)  p  value  of  the
Fisher’s  exact  test
Odds  ratio  95%  CI  range
Age
Juvenile  7  (1.7%) 0.00001 0.12 From  0.0441  to  0.3262
Adult 35  (83.3%) 0.00001 8.33 From  3.0656  to  22.6528
Sex
Male 33  (78.6%)  0.0454  2.62  From  1.0291  to  6.6652
Female 9  (21.4%)  0.0454  0.38  From  0.15  to  0.9717
Health status
Healthy  22  (52.4%)  0.67  0.77  From  0.3354  to  1.7643
Unhealthy 20  (47.6%)  0.67  1.33  From  0.5668  to  2.9816
Clinical signs
Lymph  node  enlargement 5  (11.9%) 1.00 0.95 From  0.2666  to  3.3564
Pale mucous  membranes  14  (33.3%)  0.35  1.66  From  0.6637  to  4.262
Oral disease  18  (42.9%)  0.39  1.50  From  0.637  to  3.5325
Respiratory  tract  infection  signs  11  (26.2%)  0.31  1.77  From  0.637  to  4.9419
Ocular infection  signs  9  (21.4%)  1.00  1.04  From  0.3759  to  2.8573
Skin infections  16  (38.1%)  0.04  2.67  From  1.0255  to  6.9341
CBC abnormalities
Anemia  21  (50%)  0.01  3.36  From  1.3608  to  8.3142
Leukopenia 2  (4.76%)  0.44  0.43  From  0.0789  to  2.3431
Leukocytosis  2  (4.76%)  0.68  0.55  From  0.0955  to  3.1669
Neutrophilia  6  (14.3%)  0.78  0.83  From  0.2638  to  2.6326
Neutropenia  2  (4.76%)  1.00  0.75  From  0.1192  to  4.7187
Lymphocytosis  1  (2.38%)  1.00  1.15  From  0.0695  to  18.914
Lymphopenia 25  (59.5%)  0.0337  2.68  From  1.1415  to  6.3001
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ased  on  the  stage  of  the  disease.  For  example,  when  a
uspected  FeLV  positive  animal  has  to  be  tested,  a  n-PCR
ssay  would  be  the  most  suitable  test  because  this  method
etects  animals  in  the  latent  stage  of  infection  as  well.  In
his  period,  there  is  neither  detectable  viremia  nor  circu-
ating  antigens  present  and  thus  tests  like  the  IA  assay  that
etect  circulating  antigens  would  probably  give  a  false  neg-
tive  result.  For  FIV,  the  few  discrepancies  found  between
he  two  assays  could  be  due,  according  to  our  experience,  to
nimals  that  were  in  a  period  of  lymphocyte  CD4+  depletion
uring  the  chronic  phase  of  the  disease  when  clinical  signs
ppear.  In  this  case,  when  a  blood  sample  with  a  small  num-
er  of  or  no  polymorphonuclear  cells  present  is  obtained,
egligible  amounts  of  viral  genomic  DNA  from  infected  lym-
hocytes  are  obtained,  making  the  PCR  detection  extremely
ifﬁcult.  In  these  animals,  the  optimal  methodology  would
e  to  perform  an  antibody  test  detection  similar  to  the  IA
ssay.  However,  in  kittens  where  FIV  maternal  antibodies
re  still  present  the  IA  assay  would  result  in  false  positive
nimals,  and  consequently,  it  would  be  necessary  to  retest
hem  six  months  later  or  to  perform  an  n-PCR  assay.
With  regard  to  the  clinical  history  data,  a  higher  preva-
ence  in  male  than  in  female  cats  was  found  (Table  2).
e  believe  that  this  difference  is  due  to  the  character-
stic  male  behavior  in  this  species.  Similarly  to  what  has
een  described  by  other  authors,  we  evidenced  a higher
n
i
e
irevalence  of  oral  lesions  in  FIV  infected  cats  in  comparison
o  negative  cats.  The  percentage  of  oral  disease  in  positive
nimals  was  similar  to  that  in  other  works  recently  published
y  Kornya  et  al.10 (40.6%).
With  respect  to  complete  blood  count  abnormalities,  we
bserved  that  almost  60%  of  positive  cats  showed  lymphope-
ia,  similarly  to  what  has  been  published  by  Spada  et  al.15
58.3%)  (Table  2).  In  spite  of  the  presence  of  lymphope-
ia  as  well  as  lymphadenopathy,  as  have  been  previously
eported  by  other  authors,  we  did  not  consider  them  spe-
iﬁc  of  these  retroviruses.  However,  we  found  differences
n  the  percentage  rate  of  anemia  (50%  versus  91.7%).
Our  ﬁndings  reveal  that  70%  of  positive  cats  had  had
ontact  with  the  outside  environment  or  other  cats,  empha-
izing  the  importance  for  maintaining  them  isolated  from
he  contact  with  other  animals,  especially  in  catteries.  In
ddition,  they  should  be  tested  regularly  to  allow  only  the
eproduction  of  negative  animals.  Stray  cats  might  represent
 risk  factor  for  naïve  cats.  This  kind  of  measures  would  also
revent  infected  cats  from  having  contact  with  wild  felines,
hus  preserving  their  health  status.
Although  the  number  of  samples  tested  in  our  study  is
ot  representative  of  the  real  prevalence  of  these  diseases
n  the  entire  country,  the  data  obtained  provides  the  ﬁrst
vidence  of  the  circulation  of  both  viruses  in  domestic  cats
n  our  territory.
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